<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lu J</submitter><funding>Wu Jieping Medical Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>National Key Research and Development Program of China</funding><pagination>375</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11270788</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Olanzapine (OLZ) reverses chronic stress-induced anxiety. Chronic stress promotes cancer development via abnormal neuro-endocrine activation. However, how intervention of brain-body interaction reverses chronic stress-induced tumorigenesis remains elusive.&lt;h4>Methods&lt;/h4>Kras&lt;sup>LSL-G12D/WT&lt;/sup> lung cancer model and LLC1 syngeneic tumor model were used to study the effect of OLZ on cancer stemness and anxiety-like behaviors. Cancer stemness was evaluated by qPCR, western-blotting, immunohistology staining and flow-cytometry analysis of stemness markers, and cancer stem-like function was assessed by serial dilution tumorigenesis in mice and extreme limiting dilution analysis in primary tumor cells. Anxiety-like behaviors in mice were detected by elevated plus maze and </pubmed_abstract><journal>Cell communication and signaling : CCS</journal><pubmed_title>Olanzapine suppresses mPFC activity-norepinephrine releasing to alleviate CLOCK-enhanced cancer stemness under chronic stress.</pubmed_title><pmcid>PMC11270788</pmcid><funding_grant_id>No. 82373096</funding_grant_id><funding_grant_id>2023HZ060</funding_grant_id><funding_grant_id>2022YFA1104002</funding_grant_id><funding_grant_id>No. 82273480</funding_grant_id><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Meng P</pubmed_authors><pubmed_authors>Kelley KW</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Su K</pubmed_authors><pubmed_authors>Lv D</pubmed_authors><pubmed_authors>Luo H</pubmed_authors><pubmed_authors>Zhao Z</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Peng F</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Lu J</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>He B</pubmed_authors><pubmed_authors>Cui B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Olanzapine suppresses mPFC activity-norepinephrine releasing to alleviate CLOCK-enhanced cancer stemness under chronic stress.</name><description>&lt;h4>Background&lt;/h4>Olanzapine (OLZ) reverses chronic stress-induced anxiety. Chronic stress promotes cancer development via abnormal neuro-endocrine activation. However, how intervention of brain-body interaction reverses chronic stress-induced tumorigenesis remains elusive.&lt;h4>Methods&lt;/h4>Kras&lt;sup>LSL-G12D/WT&lt;/sup> lung cancer model and LLC1 syngeneic tumor model were used to study the effect of OLZ on cancer stemness and anxiety-like behaviors. Cancer stemness was evaluated by qPCR, western-blotting, immunohistology staining and flow-cytometry analysis of stemness markers, and cancer stem-like function was assessed by serial dilution tumorigenesis in mice and extreme limiting dilution analysis in primary tumor cells. Anxiety-like behaviors in mice were detected by elevated plus maze and </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-06-01T09:03:03.739Z</modification><creation>2025-08-31T03:04:52.327Z</creation></dates><accession>S-EPMC11270788</accession><cross_references><pubmed>39054537</pubmed><doi>10.1186/s12964-024-01747-y</doi></cross_references></HashMap>